CHARLOTTE, N.C., Feb. 7 /PRNewswire-FirstCall/ -- MedCath
Corporation (NASDAQ:MDTH), a healthcare provider focused on high
acuity healthcare services, predominately the diagnosis and
treatment of cardiovascular disease, today announced its operating
results for its first fiscal quarter, which ended December 31,
2007. First Quarter 2008 Results During its fourth quarter of
fiscal 2007, MedCath completed the recapitalization of Harlingen
Medical Center ("HMC"). As part of the recapitalization, MedCath's
ownership in HMC was reduced from a majority ownership of 51.0% to
a minority ownership of 36.0%. Due to this change in ownership,
MedCath began accounting for HMC as an equity investment in the
quarter ended September 30, 2007. As such, MedCath's consolidated
operating results for the quarter ended December 31, 2007 exclude
net revenue, income from operations and Adjusted EBITDA of HMC. In
comparison, MedCath's consolidated results for the comparable
quarter of the previous fiscal year include the consolidated
financial results of HMC. As detailed below, any reduction in
MedCath's primary consolidated financial measures is due to the
reclassification of HMC from a consolidated subsidiary to an equity
investment. MedCath's reported net revenue decreased 6.8% to $163.7
million in the first quarter of fiscal 2008 from $175.5 million in
the first quarter of fiscal 2007, which included $18.4 million
attributable to HMC. Excluding this amount from prior year's
results, net revenue increased 4.2%. Income from operations
increased 6.4% to $11.4 million in the first quarter of fiscal 2008
from $10.7 million in the first quarter of fiscal 2007, which
included $0.9 million attributable to HMC. Excluding this amount
from prior year's results, income from operations increased 15.6%.
Adjusted EBITDA in the first quarter of fiscal 2008 increased 12.2%
to $23.5 million from $20.9 million in the first quarter of fiscal
2007, which included $2.1 million attributable to HMC. Excluding
this amount from prior year's results, Adjusted EBITDA increased
25.0%. Income from continuing operations was $3.3 million, or $0.15
per diluted share, in the first quarter of fiscal 2008, compared to
income from continuing operations of $254,000, or $0.01 per diluted
share, in the first quarter of fiscal 2007. MedCath's first quarter
of fiscal 2007 income from continuing operations would have been
$0.7 million, or $0.03 per diluted share, had HMC been accounted
for as an equity investment in the first quarter of fiscal 2007.
MedCath's operating results for the quarter ended December 31, 2007
reflect the following items that collectively negatively impacted
net revenue $0.2 million, Adjusted EBITDA $0.6 million and diluted
earnings per share $0.02: -- A $0.2 million, or net impact of $0.01
per diluted share, decrease in net revenue and Adjusted EBITDA
related to settlement of third-party cost reports during the
quarter, and -- A $0.4 million, or net impact of $0.01 per diluted
share, decrease in Adjusted EBITDA related to senior management
severance expense and higher professional fees incurred for
implementation of the Company's business continuity plan during the
quarter. MedCath's first quarter of fiscal 2007 results were
negatively impacted by a $2.7 million reduction in net revenue and
Adjusted EBITDA and a $3.7 million, or $0.18 per diluted share,
reduction in income from continuing operations. Share-based
compensation expense totaled $3.7 million, or $0.12 per diluted
share, in the first quarter of fiscal 2008, compared to $1.0
million, or $0.03 per diluted share, in the first quarter of fiscal
2007. Pre-opening expenses totaled $0.2 million, or $0.01 per
diluted share, in the first quarter of fiscal 2008. MedCath did not
incur pre-opening expenses in the first quarter of fiscal 2007.
Adjusted EBITDA in this release does not include share-based
compensation expense or pre-opening expenses, but these expenses
are included as a component of income from continuing operations.
"We experienced a strong start to fiscal 2008, driven by strategic
and operating initiatives upon which we embarked two years ago and
that are the foundation for our successes in this and previous
quarters," said O. Edwin French, MedCath's president and chief
executive officer. "Our hospitals had strong inpatient and
outpatient volumes, and our operating initiatives allowed us to
expand our Adjusted EBITDA and increase our EPS during the
quarter." Operating Statistics and Cash Flow Same facility hospital
adjusted admissions for the first quarter of fiscal 2008 increased
6.4% from the first quarter of the previous fiscal year. Same
facility hospital net revenue increased 4.6% after adjusting first
quarter of 2007's revenue for a reimbursement adjustment that
reduced net revenue by $2.7 million. Net cash provided by operating
activities of continuing operations for the first quarter of fiscal
2008 was $0.7 million, down from $11.4 million for the first
quarter of fiscal 2007. This decrease was due to the payment of a
previously announced $5.8 million settlement between one of
MedCath's hospitals and the United States Department of Justice and
a $9.2 million increase in cash tax payments during the first
quarter of fiscal 2008 in comparison to the first quarter of fiscal
2007. Capital expenditures, including $4.6 million in expenditures
related to MedCath's growth initiatives, totaled $14.3 million in
the first quarter of fiscal 2008 in comparison to $3.5 million in
the first quarter of fiscal 2007. Use of Non-GAAP Financial
Measures This release contains measures of MedCath's historical
financial performance that are not calculated and presented in
conformity with generally accepted accounting principles ("GAAP"),
including Adjusted EBITDA. Adjusted EBITDA represents MedCath's
income from continuing operations before interest expense; interest
and other income, net; income tax expense; depreciation;
amortization; share-based compensation expense; pre-opening
expenses; loss on disposal of property, equipment and other assets;
loss on early extinguishment of debt; equity in net earnings of
unconsolidated affiliates; minority interest share of earnings of
consolidated subsidiaries, share-based compensation, and
pre-opening expenses. MedCath's management uses Adjusted EBITDA to
measure the performance of the company's various operating
entities, to compare actual results to historical and budgeted
results, and to make capital allocation decisions. Management
provides Adjusted EBITDA to investors to assist them in performing
their analyses of MedCath's historical operating results. Further,
management believes that many investors in MedCath also invest in,
or have knowledge of, other healthcare companies that use Adjusted
EBITDA as a financial performance measure. Because Adjusted EBITDA
is a non- GAAP measure, Adjusted EBITDA, as defined above, may not
be comparable to other similarly titled measures of other
companies. MedCath has included a supplemental schedule with the
financial statements that accompanies this press release that
reconciles historical Adjusted EBITDA to MedCath's income from
continuing operations. Management will discuss and answer questions
regarding MedCath's quarterly results today during a 10 a.m. ET
conference call. In the United States, you may participate by
dialing (877) 697-5351. International callers should dial (706)
634-0602. The conference ID for both domestic and international
callers is 32448859. A live web cast will also be available on the
company's web site, http://www.medcath.com/. This information will
be available on the web site on or immediately following the
conference call for 30 days. A recorded replay of the call will be
available until 11:59 p.m. ET, February 14, 2008. To access the
replay, domestic callers should dial (800) 642-1687 and
international callers should dial (706) 645-9291. The archived
conference ID is 32448859. This press release and the financial
information included therewith will be accessible on the web, by
going to http://www.medcath.com/, "Investor Relations," then
clicking on "News." MedCath Corporation, headquartered in
Charlotte, N.C., is a healthcare provider focused on high acuity
services, the majority of which currently involve the diagnosis and
treatment of cardiovascular disease. MedCath owns interests in and
operates ten hospitals with a total of 663 licensed beds, located
in Arizona, Arkansas, California, Louisiana, New Mexico, Ohio,
South Dakota, and Texas. In addition, MedCath and its subsidiary
MedCath Partners provide services in diagnostic and therapeutic
facilities in various states. Parts of this announcement contain
forward-looking statements that involve risks and uncertainties.
Although management believes that these forward- looking statements
are based on reasonable assumptions, these assumptions are
inherently subject to significant economic, regulatory and
competitive uncertainties and contingencies that are difficult or
impossible to predict accurately and are beyond our control
including, but not limited to, enactment of changes in federal law
that would limit physician hospital ownership. Actual results could
differ materially from those projected in these forward- looking
statements. We do not assume any obligation to update these
statements in a news release or otherwise should material facts or
circumstances change in ways that would affect their accuracy.
These various risks and uncertainties are described in detail in
"Risk Factors" in MedCath's Annual Report or Form 10-K for the year
ended September 30, 2007 filed with the Securities and Exchange
Commission on December 14, 2007. Copies of this form including
exhibits are available on the internet site of the Securities and
Exchange Commission at http://www.sec.gov/. MEDCATH CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per
share data) (Unaudited) Three Months Ended December 31, 2007 2006
Net revenue $163,664 $175,549 Operating expenses: Personnel expense
55,941 57,175 Medical supplies expense 43,656 48,170 Bad debt
expense 12,173 13,831 Other operating expenses 32,110 36,465
Pre-opening expenses 248 - Depreciation 7,960 8,869 Amortization
127 252 Loss on disposal of property, equipment and other assets 28
57 Total operating expenses 152,243 164,819 Income from operations
11,421 10,730 Other income (expenses): Interest expense (4,032)
(7,458) Loss on early extinguishment of debt - (4,480) Interest and
other income, net 1,172 2,725 Equity in net earnings of
unconsolidated affiliates 2,025 1,438 Total other expenses, net
(835) (7,775) Income from continuing operations before minority
interest and income taxes 10,586 2,955 Minority interest share of
earnings of consolidated subsidiaries (4,736) (2,480) Income from
continuing operations before income taxes 5,850 475 Income tax
expense 2,595 221 Income from continuing operations 3,255 254 Loss
from discontinued operations, net of taxes (191) (5,150) Net income
(loss) $3,064 $(4,896) Earnings (loss) per share, basic Continuing
operations $0.15 $0.01 Discontinued operations (0.01) (0.25)
Earnings (loss) per share, basic $0.14 $(0.24) Earnings (loss) per
share, diluted Continuing operations $0.15 $0.01 Discontinued
operations (0.01) (0.25) Earnings (loss) per share, diluted $0.14
$(0.24) Weighted average number of shares, basic 21,028 20,121
Dilutive effect of stock options and restricted stock 263 -
Weighted average number of shares, diluted 21,291 20,121 MEDCATH
CORPORATION SELECTED OPERATING DATA (In thousands, except per share
data and selected operating data) (Unaudited) Three Months Ended
December 31, 2007 2006 % Change Statement of Operations Data: Net
revenue $163,664 $175,549 (6.8)% Adjusted EBITDA (1) $23,493
$20,934 12.2% Income from operations $11,421 $10,730 6.4% Income
from continuing operations $3,255 $254 1181.5% Earnings per share
from continuing operations, basic $0.15 $0.01 1400.0% Earnings per
share from continuing operations, diluted $0.15 $0.01 1400.0% (1)
See Supplemental Financial Disclosure -- Reconciliation of GAAP
Financial Measures to Non-GAAP Financial Measures. Three Months
Ended December 31, 2007 2006 % Change Selected Operating Data (a):
Number of hospitals 8 9 Licensed beds (c) 468 580 Staffed and
available beds (d) 451 563 Admissions (e) 8,055 9,730 (17.2)%
Adjusted admissions (f) 10,976 13,345 (17.8)% Patient days (g)
28,584 34,089 (16.1)% Adjusted patient days (h) 39,102 46,520
(15.9)% Average length of stay (days) (i) 3.55 3.50 1.4% Occupancy
(j) 68.9% 65.8% Inpatient catheterization procedures (k) 4,555
4,858 (6.2)% Inpatient surgical procedures (l) 2,099 2,516 (16.6)%
Hospital net revenue $151,965 $161,058 (5.6)% Selected Operating
Data -- Same Facility (a): Number of hospitals 8 8 Licensed beds
(c) 468 468 Staffed and available beds (d) 451 451 Admissions (e)
8,055 7,904 1.9% Adjusted admissions (f) 10,976 10,311 6.4% Patient
days (g) 28,584 28,775 (0.7)% Adjusted patient days (h) 39,102
37,711 3.7% Average length of stay (days) (i) 3.55 3.64 (2.5)%
Occupancy (j) 68.9% 69.4% Inpatient catheterization procedures (k)
4,555 4,679 (2.7)% Inpatient surgical procedures (l) 2,099 2,098
0.0% Hospital net revenue $151,965 $142,604 6.6% Combined Operating
Data (b): Number of hospitals 10 10 Licensed beds (c) 635 635
Staffed and available beds (d) 614 618 Admissions (e) 10,674 10,691
(0.2)% Adjusted admissions (f) 15,314 14,422 6.2% Patient days (g)
36,849 37,578 (1.9)% Adjusted patient days (h) 52,440 50,431 4.0%
Average length of stay (days) (i) 3.45 3.51 (1.7)% Occupancy (j)
65.2% 66.1% Inpatient catheterization procedures (k) 5,282 5,482
(3.6)% Inpatient surgical procedures (l) 2,838 2,766 2.6% Hospital
net revenue $191,520 $178,377 7.4% (a) Selected operating data
includes consolidated hospitals in operation as of the end of the
period reported in continuing operations but does not include
hospitals which are accounted for using the equity method or as
discontinued operations in our consolidated financial statements.
Same facility for all periods presented excludes Harlingen Medical
Center. (b) Combined operating data includes hospitals in operation
as of the end of the period reported in continuing operations
including hospitals which are accounted for using the equity method
in our consolidated financial statements. (c) Licensed beds
represent the number of beds for which the appropriate state agency
licenses a facility regardless of whether the beds are actually
available for patient use. (d) Staffed and available beds represent
the number of beds that are readily available for patient use at
the end of the period. (e) Admissions represent the number of
patients admitted for inpatient treatment. (f) Adjusted admissions
is a general measure of combined inpatient and outpatient volume.
We computed adjusted admissions by dividing gross patient revenue
by gross inpatient revenue and then multiplying the quotient by
admissions. (g) Patient days represent the total number of days of
care provided to inpatients. (h) Adjusted patient days is a general
measure of combined inpatient and outpatient volume. We computed
adjusted patient days by dividing gross patient revenue by gross
inpatient revenue and then multiplying the quotient by patient
days. (i) Average length of stay (days) represents the average
number of days inpatients stay in our hospitals. (j) We computed
occupancy by dividing patient days by the number of days in the
period and then dividing the quotient by the number of staffed and
available beds. (k) Inpatients with a catheterization procedure
represent the number of inpatients with a procedure performed in
one of the hospitals' catheterization labs during the period. (l)
Inpatient surgical procedures represent the number of surgical
procedures performed on inpatients during the period. MEDCATH
CORPORATION SUPPLEMENTAL FINANCIAL DISCLOSURE -- RECONCILIATION OF
GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES (Unaudited)
The following table reconciles Adjusted EBITDA with MedCath's
income from continuing operations as derived directly from
MedCath's consolidated financial statements for the three months
ended December 31, 2007 and 2006. Three Months Ended December 31,
2007 2006 (in thousands) Income from continuing operations $3,255
$254 Add: Income tax expense 2,595 221 Minority interest share of
earnings of consolidated subsidiaries 4,736 2,480 Equity in net
earnings of unconsolidated affiliates (2,025) (1,438) Interest and
other income, net (1,172) (2,725) Loss on early extinguishment of
debt - 4,480 Interest expense 4,032 7,458 Loss on disposal of
property, equipment and other assets 28 57 Amortization 127 252
Depreciation 7,960 8,869 Pre-opening expenses 248 - Share-based
compensation expense 3,709 1,026 Adjusted EBITDA $23,493 $20,934
The following table presents MedCath's condensed statement of
operations data for the quarter ended December 31, 2006 on a pro
forma basis to reflect the reclassification of Harlingen Medical
Center (HMC) from a consolidated subsidiary to an equity method
investment. Three Months Ended December 31, Adjustments to 2006
Deconsolidate 2006 (Actual) HMC (Pro Forma) 2007 (in thousands) Net
Revenue $175,549 $(18,454) $157,095 $163,664 Income from operations
10,730 (850) 9,880 11,421 Income from continuing operations before
minority interest and income taxes 2,955 761 3,716 10,586 Income
from continuing operations before income taxes 475 761 1,236 5,850
Income from continuing operations 254 407 661 3,255 Net income
(loss) $(4,896) $407 $(4,489) $3,064 Earnings (loss) per share,
basic $(0.24) $0.02 $(0.22) $0.14 Earnings (loss) per share,
diluted $(0.24) $0.02 $(0.22) $0.14 Weighted average number of
shares, basic 20,121 - 20,121 21,028 Dilutive effect of stock
options and restricted stock - - - 263 Weighted average number of
shares, diluted 20,121 - 20,121 21,291 DATASOURCE: MedCath
Corporation CONTACT: O. Edwin French, President/Chief Executive
Officer, or Art Parker, Interim Chief Financial Officer, both of
MedCath Corporation, +1-704-708-6600 Web site:
http://www.medcath.com/
Copyright
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024